<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02664701</url>
  </required_header>
  <id_info>
    <org_study_id>PHRC-N/2014/MA-01</org_study_id>
    <secondary_id>2015-A01585-44</secondary_id>
    <nct_id>NCT02664701</nct_id>
  </id_info>
  <brief_title>Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts</brief_title>
  <acronym>G-PACTS</acronym>
  <official_title>Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts: a Multicentre, Assessor-blinded, 2-parallel-group, Randomised, Superiority Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate the efficacy of a program of 6 sessions of&#xD;
      Cognitive Behavioural Group Therapy (CBGT) (as compared to 6 sessions of Individual&#xD;
      Supportive Therapy (IST)) designed for preventing repeat suicide attempts at 12 months&#xD;
      post-psychotherapy in adults admitted to inpatient care for suicide attempts.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The secondary objectives of this study are to assess the efficacy of CBGT on:&#xD;
&#xD;
      A. parameters describing the incidence of suicide and repeat suicide attempts, as well as&#xD;
      suicide re-attempt free follow-up time,&#xD;
&#xD;
      B. long-term changes in suicidal ideation,&#xD;
&#xD;
      C. long-term changes in psychiatric symptoms (depression, hope for the future,&#xD;
      hospitalization).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 17, 2017</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary clinical endpoint is the duration (in days) of a suicide reattempt-free follow-up period</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Columbia suicide severity rating scale (C-SSRS)</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Columbia suicide severity rating scale (C-SSRS)</measure>
    <time_frame>in the 10 days after the end of psychotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Columbia suicide severity rating scale (C-SSRS)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Columbia suicide severity rating scale (C-SSRS)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Columbia suicide severity rating scale (C-SSRS)</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Columbia suicide severity rating scale (C-SSRS)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Completed suicide (yes/no)</measure>
    <time_frame>in the 10 days after the end of psychotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Completed suicide (yes/no)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Completed suicide (yes/no)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Completed suicide (yes/no)</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Completed suicide (yes/no)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of suicide re-attempts during the follow-up period.</measure>
    <time_frame>in the 10 days after the end of psychotherapy</time_frame>
    <description>A suicide attempt is defined as either an &quot;actual attempt&quot; or an &quot;interrupted attempt&quot; using the definitions in the C-SSRS assessment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of suicide re-attempts during the follow-up period.</measure>
    <time_frame>3 months</time_frame>
    <description>A suicide attempt is defined as either an &quot;actual attempt&quot; or an &quot;interrupted attempt&quot; using the definitions in the C-SSRS assessment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of suicide re-attempts during the follow-up period.</measure>
    <time_frame>6 months</time_frame>
    <description>A suicide attempt is defined as either an &quot;actual attempt&quot; or an &quot;interrupted attempt&quot; using the definitions in the C-SSRS assessment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of suicide re-attempts during the follow-up period.</measure>
    <time_frame>9 months</time_frame>
    <description>A suicide attempt is defined as either an &quot;actual attempt&quot; or an &quot;interrupted attempt&quot; using the definitions in the C-SSRS assessment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of suicide re-attempts during the follow-up period.</measure>
    <time_frame>12 months</time_frame>
    <description>A suicide attempt is defined as either an &quot;actual attempt&quot; or an &quot;interrupted attempt&quot; using the definitions in the C-SSRS assessment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Suicide Ideation Scale (BSSI)</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Suicide Ideation Scale (BSSI)</measure>
    <time_frame>in the 10 days after the end of psychotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Suicide Ideation Scale (BSSI)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Suicide Ideation Scale (BSSI)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Suicide Ideation Scale (BSSI)</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Suicide Ideation Scale (BSSI)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory-II (BDI-II)</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory-II (BDI-II)</measure>
    <time_frame>in the 10 days after the end of psychotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory-II (BDI-II)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory-II (BDI-II)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory-II (BDI-II)</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory-II (BDI-II)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Hopelessness Scale (BHS)</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Hopelessness Scale (BHS)</measure>
    <time_frame>in the 10 days after the end of psychotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Hopelessness Scale (BHS)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Hopelessness Scale (BHS)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Hopelessness Scale (BHS)</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Hopelessness Scale (BHS)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative days of hospitalization</measure>
    <time_frame>in the 10 days after the end of psychotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative days of hospitalization</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative days of hospitalization</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative days of hospitalization</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative days of hospitalization</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Suicidal Ideation</condition>
  <condition>Suicide, Attempt</condition>
  <arm_group>
    <arm_group_label>Individual supportive therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to this arm will have individual supportive therapy.&#xD;
Intervention: Baseline evaluation with a psychiatrist&#xD;
Intervention: Individual supportive therapy&#xD;
Intervention: Evaluations with a psychiatrist</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cognitive behavioural group therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to this arm will have cognitive behavioural therapy.&#xD;
Intervention: Baseline evaluation with a psychiatrist&#xD;
Intervention: Cognitive behavioural group therapy&#xD;
Intervention: Evaluations with a psychiatrist</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Baseline evaluation with a psychiatrist</intervention_name>
    <description>Baseline data and questionnaires are established.</description>
    <arm_group_label>Cognitive behavioural group therapy</arm_group_label>
    <arm_group_label>Individual supportive therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Individual supportive therapy</intervention_name>
    <description>6 sessions of individual supportive therapy with a psychologist, 1 session per week for 6 weeks</description>
    <arm_group_label>Individual supportive therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cognitive behavioural group therapy</intervention_name>
    <description>6 sessions of cognitive behavioural group therapy with a psychologist, 1 session per week for 6 weeks</description>
    <arm_group_label>Cognitive behavioural group therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Evaluations with a psychiatrist</intervention_name>
    <description>Evaluation withs a psychiatrist in the 10 days following the end of psychotherapy, then at 3, 6, 9, and 12 months.</description>
    <arm_group_label>Cognitive behavioural group therapy</arm_group_label>
    <arm_group_label>Individual supportive therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient has been correctly informed&#xD;
&#xD;
          -  The patient must have given his/her informed and signed consent&#xD;
&#xD;
          -  The patient must be insured or beneficiary of a health insurance plan&#xD;
&#xD;
          -  French speaking adults (18 years or older) freely hospitalized (in centres or via&#xD;
             emergency services) for prevention of suicide and who have a medium or high suicide&#xD;
             risk score according to a Mini International Neuropsychiatric Interview structured&#xD;
             interview&#xD;
&#xD;
          -  Presence of suicidal ideation according to the Beck Suicide Ideation Scale (score &gt; 3)&#xD;
&#xD;
          -  Prior (or recent) suicide attempt&#xD;
&#xD;
          -  The patient is able to understand the study and capable of giving his/her informed&#xD;
             consent&#xD;
&#xD;
          -  The patient is available during the weekly time slots proposed by the investigator&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient is participating in another study that may interfere with the results or&#xD;
             conclusions of this study&#xD;
&#xD;
          -  Within the past three months, the patient has participated in another study that may&#xD;
             interfere with the results or conclusions of this study&#xD;
&#xD;
          -  The patient is in an exclusion period determined by a previous study&#xD;
&#xD;
          -  The patient is under judicial protection, or is an adult under guardianship&#xD;
&#xD;
          -  The patient refuses to sign the consent, or it is impossible to correctly inform the&#xD;
             patient&#xD;
&#xD;
          -  Emergency situations preventing proper study conduct&#xD;
&#xD;
          -  History of schizophrenia or other psychotic troubles&#xD;
&#xD;
          -  Presence of psychotic symptoms at initial interview&#xD;
&#xD;
          -  Serious cognitive impairment&#xD;
&#xD;
          -  Medical incapacity to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mocrane Abbar, MD</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mocrane Abbar, MD</last_name>
    <phone>+33.(0)4.66.68.34.26</phone>
    <email>mocrane.abbar@chu-nimes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carey Suehs, Phd</last_name>
    <phone>+33.(0)4.66.68.67.88</phone>
    <email>carey.suehs@chu-nimes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Clermont Ferrand - Hôpital Gabriel-Montpied</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Pierre-Michel Llorca, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Lyon - Groupement Hospitalier Edouard Herriot</name>
      <address>
        <city>Lyon Cedex 3</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Emmanuel Poulet, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de Montpellier - Hôpital Lapeyronie</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Philippe Courtet, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 09</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mocrane Abbar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jorge Lopez Castroman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurent Chaïb, PhD, pschologist</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Les Sophoras</name>
      <address>
        <city>Nîmes</city>
        <zip>30000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Stephane Torrès, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Henri Laborit</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Nematollah Jaafari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de Tours - Clinique Psychiatrique Universitaire</name>
      <address>
        <city>Saint Cyr sur Loire</city>
        <zip>37540</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Wissam El-Hage, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de Strasbourg - Hôpital Civil</name>
      <address>
        <city>Strasbourg Cedex</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Pierre Vidailhet, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 19, 2016</study_first_submitted>
  <study_first_submitted_qc>January 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2016</study_first_posted>
  <last_update_submitted>April 2, 2021</last_update_submitted>
  <last_update_submitted_qc>April 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Suicide</mesh_term>
    <mesh_term>Suicidal Ideation</mesh_term>
    <mesh_term>Suicide, Attempted</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

